Latest News

Investors were disappointed with Aemulus Holdings Berhad's ( KLSE:AEMULUS ) earnings, despite the strong profit...

With a price-to-earnings (or "P/E") ratio of 4.9x Korea Line Corporation ( KRX:005880 ) may be sending very bullish...

Labor dispute brings Veolia Environnement (ENXTPA:VIE) into focus A recent US labor complaint against Veolia Environmental Services, driven by allegations from Teamsters Local 63, has pushed Veolia Environnement (ENXTPA:VIE) into the spotlight for union risk, legal overhang, and potential contract implications. See our latest analysis for Veolia Environnement. Veolia Environnement’s €32.1 share price sits against a backdrop of steady momentum, with a 30-day share price return of 7.04% and a...

China Energy Development Holdings Limited ( HKG:228 ) shares have continued their recent momentum with a 29% gain in...

Why HEICO's NewSpace Power Move Is Getting Attention HEICO (HEI) is back in focus after VPT, one of its subsidiaries, introduced the VSCPL1210SG, a point of load DC, DC converter that rounds out its VSC Series NewSpace power solution. This launch gives HEICO a more complete offering across isolated DC, DC converters, point of load converters, and EMI filters, which could matter if you are tracking how the company positions itself in space related electronics. See our latest analysis for...

Andean Precious Metals Corp. recently completed a follow-on equity offering, raising C$83.11 million by issuing 7,915,000 common shares at C$10.50 each under Regulation S and Rule 144A. This capital raise expands the company’s equity base while introducing additional liquidity and potential shifts in its shareholder mix. Next, we will examine how this sizeable follow-on offering shapes Andean Precious Metals’ investment narrative and future capital allocation options. AI is about to change...

Most readers would already be aware that Japan Petroleum Exploration's (TSE:1662) stock increased significantly by 55...

Zurn Elkay Water Solutions reported past full-year 2025 results with sales of US$1.70 billion and net income of US$198.0 million, alongside quarterly earnings that exceeded analyst expectations. The company paired record sales, higher earnings per share and strong free cash flow with a 22% dividend increase, a US$160.0 million share repurchase and guidance for further core sales growth in 2026. With these results and new 2026 growth guidance, we’ll explore how Zurn Elkay’s stronger margins...

In January 2026, Redcare Pharmacy reported that Germany’s digital health agency gematik had issued draft PoPP specifications confirming continued support for smooth e-prescription redemption via the Shop Apotheke app, while phasing out the older CardLink-based VSDM++ process. The planned PoPP rollout not only maintains low-friction e-prescription use but also raises data security and introduces flexible, software-based authentication that could strengthen Redcare’s position in Germany’s...

FuelCell Energy (FCEL) has drawn fresh attention after disclosing that its employment relationship with former Executive Vice President, General Counsel and Corporate Secretary Joshua Dolger ended on January 6, 2026, under a detailed separation agreement. See our latest analysis for FuelCell Energy. At a share price of US$7.72, FuelCell Energy has seen a 5.03% 1 day share price gain, but the 7 day and 90 day share price returns of 19.50% and 9.07% declines suggest momentum has been fading,...

Why ARYZTA’s latest guidance is back in focus ARYZTA (SWX:ARYN) drew fresh attention after its 2025 sales and trading statement call on 22 January, alongside new earnings guidance for 2026 that points to revenue growth and improved performance for the year. For you as an investor, that combination of an updated outlook and a recent company communication creates a new reference point for reassessing ARYZTA’s current valuation, recent share price moves and the risks around its 2026 targets. See...

If you are wondering whether Bank of America shares still offer value at current levels, the starting point is understanding what the recent price action and fundamentals are actually implying. The stock last closed at US$55.38, with returns of 6.9% over the past 7 days, a 2.7% decline over 30 days, a 1.0% decline year to date, and gains of 20.3%, 64.1% and 89.5% over the past 1, 3 and 5 years respectively. Recent coverage of large US banks has focused on how investors are reassessing...

TransDigm Group (TDG) opened fiscal 2026 with Q1 revenue of US$2.3b and basic EPS of US$6.63, alongside net income of US$386m. This sets a clear reference point against a trailing twelve month EPS of US$31.08 on revenue of US$9.1b and net income of US$1.8b. The company has seen quarterly revenue move from US$2.0b and EPS of US$7.62 in Q1 2025 to US$2.3b and EPS of US$6.63 in Q1 2026. Over the same period, trailing twelve month revenue has shifted from US$8.2b with EPS of US$28.37 to US$9.1b...

Buying shares in the best businesses can build meaningful wealth for you and your family. While the best companies are...

If you are wondering whether Ameriprise Financial's current share price gives you genuine value, this article will help you size up what you might actually be paying for. The stock last closed at US$530.05, with returns of 6.4% over the past week, 7.3% over the last month, 7.3% year to date and 0.3% over the past year, set against longer term returns of 56.5% over three years and 166.6% over five years. Recent coverage around Ameriprise Financial has focused on its position as a large,...

Idorsia has recently announced an exclusive license and supply agreement with EMS S.A. to register and commercialize its insomnia medicine QUVIVIQ (daridorexant) across Latin America, while also presenting long-term data on lucerastat suggesting disease-modifying potential in Fabry disease at the WORLDSymposium. Together, these developments highlight Idorsia’s push to expand QUVIVIQ into new geographies and progress lucerastat toward a defined regulatory path in a rare disease setting. We’ll...

Beonic Limited ( ASX:BEO ) shareholders have had their patience rewarded with a 41% share price jump in the last month...

When close to half the companies in Korea have price-to-earnings ratios (or "P/E's") above 15x, you may consider NOROO...

Merck (MRK) has put up another solid quarter for FY 2025, with Q3 revenue of US$17.3b and basic EPS of US$2.32 alongside net income of US$5.8b. The company has seen revenue move from US$16.7b in Q3 2024 to US$17.3b in Q3 2025, while trailing twelve month EPS sits at US$7.57 and net income at US$19.0b. This gives investors a clear read on a business that is pairing sizeable sales with a thick profit margin. See our full analysis for Merck. With the latest numbers on the table, the next step is...

Why this cluster of news matters for H & M Hennes & Mauritz (OM:HM B) H & M Hennes & Mauritz (OM:HM B) just wrapped up a busy update, combining full year 2025 results, fresh sales guidance, a higher proposed dividend, and confirmation that its latest share buyback programme is complete. For the year to 30 November 2025, the company reported sales of SEK 228,285 million compared with SEK 234,478 million in the previous year, while net income was SEK 12,158 million compared with SEK 11,621...

In recent days, Scotiabank upgraded The Mosaic Company to “Outperform,” citing expectations that phosphate stripping margins are bottoming and that lower ammonia and sulphur costs could support its fertilizer business. This shift in analyst sentiment highlights how changing input cost trends and margin expectations can reshape perceptions of Mosaic’s position across the phosphate and potash markets. With this upgrade and anticipated phosphate margin recovery in focus, we’ll explore how...

The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...

Annaly Capital Management (NLY) is back in focus after reporting better than expected Q4 2025 earnings and revenue, supported by income from agency MBS, residential credit and mortgage servicing rights. See our latest analysis for Annaly Capital Management. That earnings beat has arrived after a mixed price patch, with the 1-day share price return of 1.29% and 90-day share price return of 5.21% contrasting with a 27.60% 1-year total shareholder return. This suggests momentum has been...

On average, over time, stock markets tend to rise higher. This makes investing attractive. But not every stock you buy...